Yu M J, McCowan J R, Thrasher K J, Keith P T, Luttman C A, Ho P P, Towner R D, Bertsch B, Horng J S, Um S L
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285.
J Med Chem. 1992 Feb 21;35(4):716-24. doi: 10.1021/jm00082a012.
A series of phenothiazines was synthesized and evaluated as in vitro inhibitors of iron-dependent lipid peroxidation. The MIC (minimum tested concentration that gave greater than or equal to 50% inhibition) for 2-(10H-phenothiazin-2-yloxy)-N,N-dimethylethanolamine methanesulfonate (6) was 0.26 microM. Whereas methyl substitution at N-10 diminished activity nearly 100-fold, other structural modifications such as varying the amine group, the distance separating the amine substituent from the phenothiazine nucleus, and the linking group had little effect. Compound 6 was more effective than probucol, a known antioxidant, in blocking Cu2+ catalyzed oxidation of low-density lipoprotein (LDL) as measured by competitive scavenger receptor mediated degradation of 125I-labeled acetyl-LDL by mouse peritoneal macrophage cells in vitro. At a concentration of 5 microM, compound 6 also protected primary cultures of rat hippocampal neurons exposed to hydrogen peroxide (50 microM) when assessed 18 h later by fluorescein diacetate and propidium iodide uptake.
合成了一系列吩噻嗪,并将其作为铁依赖性脂质过氧化的体外抑制剂进行评估。2-(10H-吩噻嗪-2-基氧基)-N,N-二甲基乙胺甲磺酸盐(6)的MIC(产生大于或等于50%抑制作用的最低测试浓度)为0.26微摩尔。虽然N-10位的甲基取代使活性降低了近100倍,但其他结构修饰,如改变胺基、胺取代基与吩噻嗪核之间的距离以及连接基团,影响很小。通过体外小鼠腹腔巨噬细胞竞争性清道夫受体介导的125I标记的乙酰-LDL降解来测定,化合物6在阻断Cu2+催化的低密度脂蛋白(LDL)氧化方面比已知抗氧化剂普罗布考更有效。在浓度为5微摩尔时,当18小时后通过荧光素二乙酸酯和碘化丙啶摄取进行评估时,化合物6还保护了暴露于过氧化氢(50微摩尔)的大鼠海马神经元原代培养物。